Top FDA drug regulator raises alarms about expediting approvals

by

Richard Pazdur, who assumed his new role this month, has warned that new Trump administration initiatives could be illegal and pose a risk to public health.

View original article
Contributor: Dan Diamond, Rachel Roubein